Navigation Links
Sponges as drugs

Dutch researcher Nicole de Voogd has investigated the possibilities for rearing sea sponges in Indonesia. Some of these sponges contain substances of interest to the pharmaceutical industry. As these are increasingly difficult to obtain, there is growing interest in alternative methods of exploitation, such as rearing sponges.

For her research, De Voogd described three new species of sponges and examined the interactions of four sponge species with possible spatial competitors. She discovered that as soon as certain sponge species grow over corals, the coral develops necrotic tissue. From this she concluded that the sponges concerned produce their bioactive substances to defeat spatial competitors. This is important, as in an environment without spatial competitors, such as in a sponge culture, a lower concentration of the substances of interest to the pharmaceutical industry might be produced.

Sponge culture

The researcher tried to rear 9 of the 151 species of sponge observed but was successful with only 3 species. Although the survival rates of these species were generally very high, the growth rates were very slow and unpredictable. Moreover, the reared sponges produced less of the biologically-active substances than their natural counterparts.

Although Indonesia has a very high diversity of sponge species, and therefore a large number of biologically-active substances with pharmaceutical potential, most of the species occur in relatively low densities compared to species in temperate areas. De Voogd discovered that as a result of this low natural density, surprisingly few Indonesian species are suitable for sea rearing.

Sea rearing

Sedentary marine invertebrates such as sponges, are an important source for a large variety of biologically-active substances. Until more advanced techniques such as chemical synthesis, genetic modification and sponge cell culture are realised, rearing in the sea remains the most reliable and effective method for obtaining the large quantities of sponge biomass, necessary for developing drugs.

However, sea rearing can only be used for the large-scale production of useful substances if it can yield large quantities of the sponge species. Therefore, sea rearing would only seem to be a profitable option if the quantities of the substance needed are small or if the growth can be optimised in combination with other reared organisms.

Nicole de Voogd's research was funded by NWO.


Source:Netherlands Organization for Scientific Research

Related biology news :

1. Researchers identify target for cancer drugs
2. MetaChip provides quick, efficient toxicity screening of potential drugs
3. Newly discovered pathway might help in design of cancer drugs
4. UNC launches study of liver injury caused by drugs
5. UCLA study assesses cost-effectiveness of Hepatitis B drugs
6. Recombinant DNA technology may enable oral, rather than injectable, delivery of protein drugs
7. FDA approves more generic AIDS drugs
8. Virginia Tech group adds tools to DNA-targeted anti-cancer drugs
9. Scientists discover that three molecules may be developed into new Alzheimers drugs
10. Scientists to mimic nature for newest cancer drugs
11. Bacteria are key to green plastics, drugs
Post Your Comments:

(Date:11/9/2015)... 2015  Synaptics Inc. (NASDAQ: SYNA ), the ... entry into the automotive market with a comprehensive and ... of consumer electronics human interface innovation. Synaptics, industry-leading touch ... the automotive industry and will be implemented in numerous ... , Japan , and ...
(Date:11/2/2015)... PARK, Calif. , Nov. 2, 2015  SRI ... $9 million to provide preclinical development services to the ... the contract, SRI will provide scientific expertise, modern testing ... wide variety of preclinical pharmacology and toxicology studies to ... --> The PREVENT Cancer Drug Development ...
(Date:10/29/2015)... Calif. , Oct. 29, 2015  The J. ... new report titled, "DNA Synthesis and Biosecurity: Lessons Learned ... the Department of Health and Human Services guidance for ... in 2010. --> ... it also has the potential to pose unique biosecurity ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... Studies reveal the differences in species of ... way for more effective treatment for one of the most ... --> --> Gum disease is ... yet relatively little was understood about the bacteria associated with ... by researchers from the WALTHAM Centre for Pet Nutrition together ...
(Date:11/25/2015)... Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) ... chat discussion at the Piper Jaffray 27th Annual Healthcare ... discussion is scheduled for Wednesday, December 2, at 8:00 ... replay will be available for 14 days after the ... NormartVP, Corporate Communications and Business Development , BrewLife(858) 875-8629 ...
(Date:11/24/2015)... -- Cepheid (NASDAQ: CPHD ) today announced that ... and invited investors to participate via webcast. ... 1, 2015 at 11.00 a.m. Eastern Time --> ... 1, 2015 at 11.00 a.m. Eastern Time --> ... NY      Tuesday, December 1, 2015 at 11.00 ...
(Date:11/24/2015)... , Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... IIROC on behalf of the Toronto Stock Exchange, confirms ... there are no corporate developments that would cause the ... --> --> About Aeterna Zentaris ... . --> Aeterna Zentaris is a specialty ...
Breaking Biology Technology: